NeoGenomics (NEO) Tops Q3 EPS by 6c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.14), $0.06 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $128.78 million versus the consensus estimate of $122.41 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Schneider National (SNDR) PT Raised to $34 at Stifel
• Waller: Recent Increases In Core Inflation Are Quite Broad